EI
ALIM

EAM Investors’s Alimera Sciences ALIM Stock Holding History

EAM Investors’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-13,692
Closed -$1.23M – 366
2014
Q2 		$1.23M Sell
13,692
-3,461
-20% -$307K 0.23% 235
2014
Q1 		$2.03M Buy
+17,153
New +$1.67M 0.37% 87

Other funds holding ALIM

PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

EAM Investors's ALIM Position: Q3 2014 in Review

EAM Investors sold out of Alimera Sciences (ALIM) in Q3 2014, closing a stake of 13,692 shares — an estimated $1.23M sold.

EAM Investors first reported a position in ALIM in Q1 2014 and held it in 2 quarters. The position peaked at $2.03M in Q1 2014. 60 funds tracked by Wall St. Rank hold ALIM as of Q3 2014.

  • EAM Investors reported no remaining Alimera Sciences position as of Q3 2014 after selling out during the quarter.
  • EAM Investors sold 13,692 Alimera Sciences shares in Q3 2014, an estimated $1.23M.
  • EAM Investors first reported a position in Alimera Sciences in Q1 2014 and held it in 2 quarters.
  • EAM Investors's Alimera Sciences position peaked at $2.03M in Q1 2014.
  • 60 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2014.

Based on EAM Investors's 13F filing for Q3 2014, filed 13 Nov 2014.